When a genomic alteration of SCARA3 gene was analyzed in the TCGA-data of various cancers, the frequency of deep deletion was relatively high in lung, bladder, breast, colorectal, hand and neck, and prostate cancers where SCARA3 was downregulated in cancer tissues compared to that in normal tissues. Here, SCARA3 is linked to prostate carcinoma.